Glucose has been reported to increase the de novo synthesis of diacylglycerol (DAG) and translocate and activate protein kinase C (PKC) in rat adipocytes. Presently, we examined the major subcellular site of PKC translocation/activation in response to glucose-induced DAG. Glucose rapidly increased DAG content and PKC enzyme activity in microsomes, but not in plasma membranes or other membranes, during a 30-min treatment of rat adipocytes. This glucose-induced increase in microsomal DAG was attended by increases in immunoreactive PKC a, ,B, and E. Glucose-induced activation of DAG/PKC signaling in microsomes was not associated with a change in the translocation of Glut4 transporters from microsomes to the plasma membrane, a biological response that is known to be stimulated by agonists, e.g., phorbol esters, which increase DAG/ PKC signaling in plasma membranes, as well as in microsomes. In conclusion, an increase in de novo phospholipid synthesis, as occurs during glucose treatment of rat adipocytes, primarily activates DAG/PKC signaling in microsomes; moreover, this signaling response and biological consequences thereof may differ from those of agonists that primarily stimulate DAG/PKC signaling in the plasma membrane. (J. Clin.
Introduction
Glucose has been reported to provoke rapid increases in diacylglycerol (DAG) ' ( 1, 2) and concomitantly increase the enzymatic activity (1) and/or the translocation (2) of protein kinase C (PKC) in rat adipocytes. Studies with labeled glucose in rat adipocytes have demonstrated that increases in DAG result largely, if not exclusively, from the metabolism of glucose through the pathway of de novo phospholipid (i.e., phosphatidic acid [PA] ) synthesis (2) . These changes in DAG and PKC have suggested that glucose can stimulate DAG/PKC signaling in rat adipocytes, and similar observations have been made in a variety ofother (3, 4) , but not all (e.g., see reference 5), tissues.
Glucose-induced aberrations in DAG/PKC signaling, moreover, have been postulated to play a role in the pathogenesis of diabetic complications (3, 4) , and may also be involved in the pathogenesis of insulin resistance, either by persistent PKC activation and downregulation ofinsulin receptor tyrosine kinase activity (6) or after more chronic glucose treatment, by partial depletion of PKC-f3, as shown in rat adipocytes (7) .
Although glucose appears to increase DAG/PKC signaling through stimulation of de novo PA synthesis in some tissues, it seems most likely that this DAG/PKC signaling is considerably different from that resulting from agonist-stimulated hydrolysis of phospholipids through receptor-mediated activation of phospholipase C and/or D in the plasma membrane. Such a difference may be anticipated as de novo PA and consequent DAG synthesis would be expected to occur primarily in the endoplasmic reticulum (8) rather than in the plasma membrane. Presently, we evaluated this question in rat adipocytes, both with respect to the major subcellular site ofglucose-stimulated DAG/PKC signaling and the PKC isoforms that are involved.
Methods
As described previously (2, 5, 7) , rat adipocytes were prepared by collagenase digestion of rat epididymal fat pads obtained from 200-g male Holtzman rats fed standard laboratory chow ad lib. The cells were suspended in glucose-free Krebs-Ringer phosphate buffer (KRP) containing 1% BSA, equilibrated for 30 min at 370C, and then treated with 0 (controls), 5, 10, or 20 Nuclear, Boston, MA). After this initial labeling period, the adipocytes were aliquoted into plastic tubes and treated with or without 10 mM glucose for 1-30 min (as above, the total incubation period was constant, i.e., in this case, 150 min, for all samples). Reactions were terminated by adding chilled KRP or KRB.
Unless indicated otherwise, adipocytes were washed and homogenized (Potter-Elvehjem homogenizer) in cold 0.25 M sucrose buffer containing 20 mM Tris/HCl (pH 7.5), 1.2 mM EGTA, 1 mM PMSF, 20 mM fl-mercaptoethanol, and 20 ,g/ml leupeptin (buffer I). Homogenates were centrifuged either, as described previously (2, 5, 7) , to obtain cytosol and crude, Triton X-100-solubilized, total membrane fractions, or, exactly as described by Weber et al. (9) , to obtain highly purified plasma membranes and microsomes and combined nuclearmitochondrial membrane fractions.
Immunoreactive PKC in subcellular fractions was determined by methods largely described previously (2, 5, 7) , except for the use of a chemiluminescent (ECL kit; Amersham Corp., Arlington Heights, IL) detection system in some experiments, particularly those involving purified microsomes and plasma membranes. In all experiments, equal amounts ofcytosolic or membrane protein from each ofthe treatment groups were analyzed in parallel on the same immunoblot. All anti-PKC polyclonal antisera were raised by immunization of rabbits with peptides that are contained within the variable regions (V3) ofthe catalytic domains of each PKC isoform. Antisera for PKCa, 'y, a, E, and r were obtained from Gibco (Grand Island, NY) (see references 10 and 11). Antiserum for PKCfi has been used extensively in previous studies (2, 5, 7, 11 ) and was obtained from Dr. John Mehegan and Dr. Bryan Roth, who have characterized this antiserum ( 12) . As described previously ( 11 ), the epitope-recognizing specificity of each ofthese antisera was verified by showing that immunoreactivities ofboth adipocyte samples and PKC rat brain standards were no longer apparent when assays were conducted in the presence of an excess of the immunogenic peptide, which specifically blocks those antibodies that recognize the targeted amino acid sequence. As also described previously ( 11) , (a) rat brain PKCa, f, y, a, E, and r standards (and corresponding rat adipocyte PKCs) migrated on SDS-PAGE at apparent molecular masses of 80, 80, 80, 80, 90, and 75 kD, respectively; (b) using each antiserum, there was a linear relationship between observed immunoreactivity and the amount of PKC assayed, except at saturating or extremely low amounts of PKC; and (c) each of the antisera that were used did not cross-react with PKC isoforms (within the groups a, fi, y, a, e, and O), other than that that was targeted, as tested with recombinant PKCs that were obtained from baculovirus-insect cell and NIH/3T3 cell expression systems. DAG was measured by the method of Preiss et al. ( 13) .
As described previously ( 14) , membrane PKC enzyme activity was measured in vitro by the method ofChakravarthy et al. ( 15) Table I ). In contrast, there were no significant increases in DAG contents of the plasma membrane or nuclear-mitochondrial fraction during the 30-min period of 10 mM glucose treatment ( Fig. 1 and Table I ).
Alterations in PKC enzyme activity (85-kD substrate phosphorylation in vitro.) As an indicator of PKC activation, we examined the enzymatic activity ofvarious preparations ofadipocyte membranes wherein PKC activation presumably occurs. In total postnuclear membranes that were obtained from control or glucose-treated adipocytes, 10 mM glucose provoked, over a 10-min period, increases of 150±6% (mean+SE; n = 3 experiments; P < 0.025, paired ttest), and these increases Table I for results from a larger number of experiments. Table I ). Translocation ofPKC isoforms as determined by immunoblot analysis. We have reported previously that glucose stimulates the translocation ofPKC enzyme activity and immunoreactive PKCJ3 from the cytosol to crude membrane fractions of rat adipocytes in a time-and dose-dependent manner (2, 5) .
This was presently confirmed for PKCf3 in both dose-response (Fig. 4) and time course (Fig. 5 ) experiments, and effects of 10 85 kD-. Figure 3 . Effects of glucose on PKC enzyme activity of plasma membranes (left) and microsomes (right) of rat adipocytes. Adipocytes were treated for 10 min without (control, C) or with (G) 10 mM glucose. Membranes were then analyzed for PKC enzyme activity in vitro as described in Fig. 2 . Shown here are representative autoradiograms. Also see Table I for results from multiple experiments. mM glucose were also compared with those of the phorbol ester, viz., 500 nM TPA (Fig. 5) : as is apparent, peak increases in membrane PKCI3 were frequently, although not always, observed at 5-10-min treatment with glucose or TPA, although cytosolic PKC,3 continued to decrease over a 20-min period. As is also apparent, 500 nM TPA was much more potent than 10 mM glucose in stimulating the translocation of PKC#. We also examined whether glucose provoked changes in the subcellular distribution ofseveral other PKC isoforms that are found in rat adipocytes ( 11 ) . Rat adipocytes were treated with 0 (control), 10, or 20 mM glucose for 10 min, and the cytosol and crude membrane fractions were examined for changes in their contents of various immunoreactive PKC isoforms. As shown in Fig. 6 , glucose-induced changes in PKCa or e in these crude subcellular fractions were not readily apparent, although TPA was very effective in stimulating the translocation of these isoforms from cytosol to membrane. However, as shown below, we readily detected increases in microsomal PKCa and e in Fig. 7 and Table II , there were consistent substantial increases in microsomal PKCa, (3, and E, but only a small change in PKCt. In plasma membranes, PKCa increased modestly, but PKC(3, E, and were unchanged or diminished slightly (Table II) .
MARCKSphosphorylation in intact rat adipocytes. To verify that PKC was truly activated by glucose treatment in intact adipocytes, we studied the phosphorylation ofthe specific PKC substrate, MARCKS. As shown in Fig. 8 , rapid increases in endogenous MARCKS phosphorylation were observed in intact adipocytes in response to 10 mM glucose treatment. The increases observed with 10 mM glucose treatment were less than those reported previously (see reference 17) with TPA treatment (i.e., two-to fourfold).
Glut-4 translocation. In control adipocytes, as has been reported (9, (18) (19) (20) (21) (22) brane. Whereas insulin or TPA treatment for 15 min provoked increases in Glut-4 translocation from low density microsomes (50% decreases) to the plasma membrane (two-to fourfold increases) (also reported previously, see references 20-23), 5 or 10 mM glucose treatment for 15 min had little or no effect on this process (Table III) .
Discussion
Presently, we found that glucose-induced increases in DAG content and PKC enzyme activity in the rat adipocyte were confined to or most evident in microsomal membranes, i.e., the endoplasmic reticulum, at least initially. by phorbol esters and insulin in these cells. As reported previously by Egan et al. (23) and confirmed in our laboratory using the same presently used subcellular fractionation procedures and in vitro PKC enzyme assay ( 14) , both phorbol esters and insulin provoke rapid, sustained two-to threefold increases in PKC enzyme activity of both plasma membranes and microsomes ofrat adipocytes. Furthermore, we have found that insulin rapidly increases the contents of DAG ( 14) and PKCa, [ , and e (unpublished) in both plasma membranes and microsomes. Thus, the failure of glucose to provoke increases in DAG and PKC enzyme activity in adipocyte plasma membranes cannot be attributed to insensitive assay methods. The translocation of PKC isoforms to specific intracellular membranes may be expected to result in specific alterations of PKC-dependent biological processes. It was therefore of interest to find that, although phorbol esters and insulin provoked increases in the translocation ofGlut-4 from microsomes to the plasma membrane, acute glucose treatment was inactive, or poorly active, in this regard. These findings indicate that (a) glucose-induced translocation of PKCa, [3, Finally, it should be realized that persistent PKCa activation in the plasma membrane by glucose could inhibit insulin receptor tyrosine kinase activity (see reference 6) and could thereby diminish insulin effects on various cellular processes. Also, persistent preferential activation of microsomal PKCa, [3, and e may, at least in certain tissues such as the adipocyte, lead to proteolytic degradation and diminution of the cellular content ofthese PKC isoforms. Accordingly, since insulin stim- ulates the translocation of PKCa, fl, and E to both plasma membranes and microsomes in rat adipocytes (11, 14 , and unpublished observations), it is possible that glucose-induced decreases in the availability of PKC (as occurring in rat adipocytes [2, 7 ] ) may lead to decreases in insulin-induced or other agonist-induced translocation of these PKC isoforms to the plasma membrane, and possibly to other nonmicrosomal membranes. Similarly, an increase in de novo synthesis of DAG, as occurs in denervated skeletal muscle (24), could limit insulin-induced PKC translocation to critical sites and thereby diminish insulin-stimulated glucose transport in skeletal muscle. Thus, the present findings may have relevance to the pathogenesis ofboth "glucotoxicity" and glucose-induced insulin resistance.
